Giving Snakebite Victims a Voice

Health Action International Presents “Minutes to Die” at the Dutch Global Health Film Festival

by BIRTE BOGATZ, Communications Advisor

How do you measure the burden of a health emergency? We often tend to do that by counting—the dead, the disabled, the dollars to be paid for treatment. We end up with numbers,

‘Achieiving Affordable Access to Health Technologies’ Side Event at WHA69

Health Action International is, once again, pleased to be in Geneva this week attending the 69th World Health Assembly. If you will be there, too, please plan on attending a side event on ‘Achieving Affordable Access to Health Technologies’, which we are co-organising with the Medicines for Malaria Venture and Oxfam.

The event will be held on Tuesday,

Top Experts to Discuss Global Initiatives to Reduce Snakebite Death & Disability at WHA69 Side Event

Every year, snakebite kills 125,000 people around the world and gravely injures 2.7 million more. For the first time at a World Health Assembly (WHA) side event, leading venom and snakebite experts, government representatives and medicine policy experts will discuss global challenges, initiatives and strategies to reduce death and disability from snakebite envenoming—one of the world’s most tragic and neglected tropical diseases.

Can the WHO Set the Right Course for Antibiotics?

by MATTHEW ENEVOLDSON, Communications Intern

As a typically awkward teenager, I was, as many are, occasionally afflicted by an outbreak of spots. Whilst these were embarrassing, they were by no means terrible. Even at their worst, they were nothing but a shadow of those of the kid, resident in every school, who is plagued by acne.

Successful week of advocacy for HAI delegation at 68th World Health Assembly

by TIM REED, Executive Director

Health Action International’s largest-ever team to the 68th World Health Assembly enjoyed a fruitful week of advocacy, which resulted in some major achievements, particularly related to antimicrobial resistance and World Health Organization (WHO) engagement with non-state actors. The annual Assembly was held in Geneva from 18-26 May.

The delegation was comprised of 39 insightful and talented people from ReAct–Action on Antibiotic Resistance,

World Health Assembly Executive Board 136: YP-CDN, NWIA and HAI intervention on the WHO’s internship programme

4 February 2015 | by TIM REED
At the 136th World Health Organization (WHO) Executive Board meeting in Geneva this past week, we had the privilege of developing an intervention with the Young Professionals Chronic Disease Network (YP-CDN) and the Network of WHO Intern Alumni (NWIA) regarding the WHO’s internships programme.

World Health Assembly Executive Board 136: YP-CDN and HAI intervention on the progress achieved in the prevention and control of non-communicable diseases

by KAVITHA KOLAPPA (Young Professionals Chronic Disease Network) and TIM REED (HAI)

Thank you Chair and esteemed delegates:
I am speaking on behalf of Health Action International and the Young Professionals Chronic Disease Network.
At last year’s Executive Board meeting, we heard an impassioned plea from South Africa whose draft reforms to their domestic intellectual property policy were under threat by a lobbying firm who planned a subversive campaign to block these reforms,

Hoping for "harmony" on global antibiotic resistance strategy

WHO director-general, Margaret
Chan, and HAI executive director,
Tim Reed, at a WHA67 event.

Those of us who attended the 67th World Health Assembly (WHA) in Geneva were slightly disappointed that we were not treated to the sensation of Margaret Chan (director-general of the World Health Organization) singing during this year’s meetings.

Week in review: Outcomes from WHA67


Health Action International was encouraged by the results of the 67th World Health Assembly where more than 20 resolutions were passed on various public health issues. Throughout the week, we delivered four interventions and hosted and attended important side events on access to medicines and related topics.

Progress on access to medicines at WHA67, but WHO funding sorely needed

Access to essential medicines was a hot topic at the 67th World Health Assembly (WHA) last week in Geneva. Given our ‘official relations’ status with the World Health Organization (WHO), Health Action International was pleased to deliver a number of interventions to inform discussion and advocate for medicines access issues.